Drug Type Chemical drugs |
Synonyms |
Target |
Mechanism LIFR inhibitors(LIF receptor subunit alpha inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC29H29F2NO2 |
InChIKeyYGNSFCDHJNQOOW-WKWWZUSTSA-N |
CAS Registry2806739-30-8 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Prostatic Cancer | Preclinical | US | 17 Apr 2023 | |
Prostatic Cancer | Preclinical | US | 17 Apr 2023 |